Walgreens Boots Alliance (NASDAQ:WBA) Updates FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 1.400-1.800 for the period, compared to the consensus estimate of 1.520. The company issued revenue guidance of -.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $9.22 on Friday. The firm has a 50 day moving average of $9.21 and a 200-day moving average of $9.92. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $25.63. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $7.96 billion, a PE ratio of -0.92, a PEG ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period in the prior year, the company earned $0.67 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. On average, equities research analysts predict that Walgreens Boots Alliance will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.85%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

A number of brokerages have recently commented on WBA. Morgan Stanley cut their price target on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Barclays lifted their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Evercore ISI increased their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research note on Wednesday, October 16th. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research note on Wednesday, December 4th. Finally, Jefferies Financial Group decreased their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.